(Alliance News) - European equities tumbled on Thursday, with tepid earnings causing a sea of red across major benchmarks, compounding already fragile sentiment after a sell-off in New York. Read More
(Alliance News) - Stock prices in London opened lower on Thursday, with earnings from the UK and beyond largely falling short, after sentiment was already hurt by a tech sell-off in New York. Read More
(Alliance News) - London's FTSE 100 is called to open lower on Thursday, with a sell-off of US technology shares filtering through to trade in Europe and in Asia. Read More
(Alliance News) - AstraZeneca PLC's recently announced aim of delivering USD80 billion in yearly revenue by the start of the next decade looks achievable, Shore Capital Markets said Friday, believing the drugmaker has an enviable pipeline. Read More
(Alliance News) - AstraZeneca PLC on Friday announced that its medication osimertinib, alongside chemotherapy, has been approved by the European Commission. Read More
(Alliance News) - AstraZeneca PLC on Monday said two cancer treatments had been recommended for approval in the European Union, while there was also positive news for a Covid treatment. Read More
(Alliance News) - AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day after a similar approval in Japan. Read More
(Alliance News) - AstraZeneca PLC on Tuesday reported mixed results from probes of its key cancer drug Imfinzi, with the medication succeeding in a bladder cancer trial but falling short in non-small cell lung cancer. Read More
(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslodex, for the treatment of a form of breast cancer. Read More
